PURPOSE: To pool data across multiple institutions internationally and report on the cumulative experience of brainstem stereotactic radiosurgery (SRS). METHODS AND MATERIALS: Data on patients with brainstem metastases treated with SRS were collected through the International Gamma Knife Research Foundation. Clinical, radiographic, and dosimetric characteristics were compared for factors prognostic for local control (LC) and overall survival (OS) using univariate and multivariate analyses. RESULTS: Of 547 patients with 596 brainstem metastases treated with SRS, treatment of 7.4% of tumors resulted in severe SRS-induced toxicity (grade ≥3, increased odds with increasing tumor volume, margin dose, and whole-brain irradiation). Local control at 12 months after SRS was 81.8% and was improved with increasing margin dose and maximum dose. Overall survival at 12 months after SRS was 32.7% and impacted by age, gender, number of metastases, tumor histology, and performance score. CONCLUSIONS: Our study provides additional evidence that SRS has become an option for patients with brainstem metastases, with an excellent benefit-to-risk ratio in the hands of experienced clinicians. Prior whole-brain irradiation increases the risk of severe toxicity in brainstem metastasis patients undergoing SRS.

Department of Neurological Surgery University of Pittsburgh Medical Center Pittsburgh Pennsylvania

Department of Neurosurgery Cleveland Clinic Cleveland Ohio

Department of Neurosurgery Neurological Institute Taipei Veteran General Hospital Taipei Taiwan People's Republic of China

Department of Neurosurgery New York University Lagone Medical Center New York New York

Department of Radiation and Stereotactic Neurosurgery Na Homolce Hospital Prague Czech Republic

Department of Radiation Oncology Beaumont Health System Royal Oak Michigan

Department of Radiation Oncology University of Pennsylvania Philadelphia Pennsylvania

Department of Radiation Oncology University of Virginia Charlottesville Virginia

Department of Radiation Oncology University of Virginia Charlottesville Virginia; Department of Neurological Surgery University of Virginia Charlottesville Virginia

Departments of Neurosurgery and Radiation Oncology West Virginia University Morgantown West Virginia

Division of Neurosurgery Université de Sherbrooke Centre de recherche du CHUS Sherbrooke Québec Canada

Strahlenther Onkol. 2017 Apr;193(4):347-349. doi: 10.1007/s00066-017-1112-2. PubMed

Zobrazit více v PubMed

Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–1672. PubMed

Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol. 2009;10:1037–1044. PubMed

Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322:494–500. PubMed

Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96:45–68. PubMed PMC

Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47:291–298. PubMed

O’Neill BP, Iturria NJ, Link MJ, et al. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys. 2003;55:1169–1176. PubMed

Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29:134–141. PubMed PMC

Brown PD. [Accessed February 19, 2015];N0574: Stereotactic radiation therapy with or without whole-brain radiation therapy in treating patients with brain metastases. Available at: http://meetinglibrary.asco.org/content/146056-156.

Sharma MS, Kondziolka D, Khan A, et al. Radiation tolerance limits of the brainstem. Neurosurgery. 2008;63:728–732. [discussion 732-723] PubMed

Mayo C, Yorke E, Merchant TE. Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys. 2010;76:S36–S41. PubMed PMC

Kased N, Huang K, Nakamura JL, et al. Gamma knife radiosurgery for brainstem metastases: The UCSF experience. J Neurooncol. 2008;86:195–205. PubMed

Koyfman SA, Tendulkar RD, Chao ST, et al. Stereotactic radiosurgery for single brainstem metastases: The Cleveland Clinic experience. Int J Radiat Oncol Biol Phys. 2010;78:409–414. PubMed

Hatiboglu MA, Chang EL, Suki D, et al. Outcomes and prognostic factors for patients with brainstem metastases undergoing stereotactic radiosurgery. Neurosurgery. 2011;69:796–806. [discussion 806] PubMed

Kawabe T, Yamamoto M, Sato Y, et al. Gamma Knife surgery for patients with brainstem metastases. J Neurosurg. 2012;117(Suppl.):23–30. PubMed

Sengoz M, Kabalay IA, Tezcanli E, et al. Treatment of brainstem metastases with gamma-knife radiosurgery. J Neurooncol. 2013;113:33–38. PubMed

Peterson HE, Larson EW, Fairbanks RK, et al. Gamma knife treatment of brainstem metastases. Int J Mol Sci. 2014;15:9748–9761. PubMed PMC

Kilburn JM, Ellis TL, Lovato JF, et al. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: Is there a volume threshold for toxicity? J Neurooncol. 2014;117:167–174. PubMed PMC

Lin CS, Selch MT, Lee SP, et al. Accelerator-based stereotactic radiosurgery for brainstem metastases. Neurosurgery. 2012;70:953–958. [discussion 958] PubMed

Yen CP, Sheehan J, Patterson G, et al. Gamma knife surgery for metastatic brainstem tumors. J Neurosurg. 2006;105:213–219. PubMed

Lorenzoni JG, Devriendt D, Massager N, et al. Brain stem metastases treated with radiosurgery: Prognostic factors of survival and life expectancy estimation. Surg Neurol. 2009;71:188–195. [discussion 195-186] PubMed

Leeman JE, Clump DA, Wegner RE, et al. Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases. Radiat Oncol. 2012;7:107. PubMed PMC

Shuto T, Fujino H, Asada H, et al. Gamma knife radiosurgery for metastatic tumours in the brain stem. Acta Neurochir (Wien) 2003;145:755–760. PubMed

National Insitutes of Health. National Cancer Institute [Accessed July 22, 2015];Common Terminology Criteria for Adverse Events (CTCAE) (Version 4.0). Available at: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf.

Snell JW, Sheehan J, Stroila M, et al. Assessment of imaging studies used with radiosurgery: A volumetric algorithm and an estimation of its error. Technical note. J Neurosurg. 2006;104:157–162. PubMed

Bhatnagar AK, Flickinger JC, Kondziolka D, et al. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys. 2006;64:898–903. PubMed

Valery CA, Boskos C, Boisserie G, et al. Minimized doses for linear accelerator radiosurgery of brainstem metastasis. Int J Radiat Oncol Biol Phys. 2011;80:362–368. PubMed

Huang CF, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for brainstem metastases. J Neurosurg. 1999;91:563–568. PubMed

Yoo TW, Park ES, Kwon do H, et al. Gamma knife radiosurgery for brainstem metastasis. J Korean Neurosurg Soc. 2011;50:299–303. PubMed PMC

Kelly PJ, Lin YB, Yu AY, et al. Linear accelerator-based stereotactic radiosurgery for brainstem metastases: The Dana-Farber/Brigham and Women’s Cancer Center experience. J Neurooncol. 2011;104:553–557. PubMed

Jung EW, Rakowski JT, Delly F, et al. Gamma Knife radiosurgery in the management of brainstem metastases. Clin Neurol Neurosurg. 2013;115:2023–2028. PubMed

Trifiletti DM, Lee CC, Shah N, et al. How does brainstem involvement affect prognosis in patients with limited brain metastases? Results of a matched-cohort analysis. World Neurosurg. 2016;88:563–568. PubMed